Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04361669

Hospice Quality Score Assessment Post Pharmacist Intervention

Assessing the Impact of Pharmacist Interventions on Hospice Quality Scores

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Tabula Rasa HealthCare · Industry
Sex
All
Age
18 Years – 88 Years
Healthy volunteers

Summary

The study aims to investigate the impact of pharmacist delivered interventions on hospice patients quality metric scores.

Detailed description

The objective of this study is evaluate a program at a hospice involving activities designed to improve the site's National Quality Forum (NQF) and Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores. These scores are calculated by the hospice using existing patient satisfaction survey scores (HCAHPS). The institution quantifies their compliance with national quality metrics (NQF) and reports this existing data to the pharmacist providing counseling services to their patients. The pharmacist assesses for areas for improvement and provides additional counseling services to improve the continuity and quality of care. The pilot program is scheduled to launch April 2020 and the researchers will look to assess for changes in the NQF scores, HCAHPS scores, and time for their partnering pharmacy to refill the first set of prescriptions.

Conditions

Interventions

TypeNameDescription
OTHERMedication safety reviewImplementation of a medication safety review using a clinical decision support system

Timeline

Start date
2020-04-22
Primary completion
2022-09-01
Completion
2022-09-01
First posted
2020-04-24
Last updated
2022-09-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04361669. Inclusion in this directory is not an endorsement.